This content is machine translated Allergic rhinitis International consensus paper summarizes important facts The “International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis” (ICAR: AR 2023) is a valuable tool to overcome therapeutic inertia and achieve the best possible outcomes in the treatment…
View Post 6 min This content is machine translated Chronic itching Non-trivial – despite proven and new system therapies Chronic pruritus can occur at any age and affect different groups of patients. A guideline-based approach is advisable in order to determine the cause and provide the best possible treatment…
View Post 4 min This content is machine translated Prurigo nodularis When excruciating itching proves to be persistent – what helps? Chronic prurigo is characterized by an “itch-scratch cycle” and is often associated with high levels of distress. The International Forum for the Study of Itch (IFSI) suggests a stage-adapted multimodal…
View Post 4 min This content is machine translated Mast cell activation syndrome (MCAS) Practice-relevant findings up-to-date The enzyme tryptase, which is produced almost exclusively by mast cells, is considered a significant parameter in suspected MCAS. If the event-related increase in tryptase compared with symptom-free intervals exceeds…
View Post 4 min This content is machine translated Chronic spontaneous urticaria When antihistamines are not enough – ligelizumab soon available in addition to omalizumab? The biologic omalizumab has empirically well-documented efficacy and safety and is considered the treatment of choice in international guidelines for cases of chronic spontaneous urticaria with inadequate response to antihistamines.…
